Double transcranial direct current stimulation of the brain increases cerebral energy levels and systemic glucose tolerance in men.
Adenosine Triphosphate
/ analysis
Adrenal Glands
/ physiology
Adult
Blood Glucose
/ analysis
Brain
/ physiology
Brain Chemistry
/ physiology
Cross-Over Studies
Energy Metabolism
/ physiology
Glucose
/ metabolism
Glucose Clamp Technique
Glucose Tolerance Test
Humans
Hydrocortisone
/ blood
Hypothalamo-Hypophyseal System
/ physiology
Magnetic Resonance Spectroscopy
Male
Phosphocreatine
/ analysis
Single-Blind Method
Stress, Physiological
/ physiology
Transcranial Direct Current Stimulation
tDCS
brain stimulation
cerebral high-energy phosphates
healthy humans
hypothalamic-pituitary-adrenal axis
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
30
03
2018
revised:
14
12
2018
accepted:
15
01
2019
pubmed:
20
1
2019
medline:
22
7
2020
entrez:
20
1
2019
Statut:
ppublish
Résumé
Transcranial direct current stimulation (tDCS) is a neuromodulatory method that has been tested experimentally and has already been used as an adjuvant therapeutic option to treat a number of neurological disorders and neuropsychiatric diseases. Beyond its well known local effects within the brain, tDCS also transiently promotes systemic glucose uptake and reduces the activity of the neurohormonal stress axes. We aimed to test whether the effects of a single tDCS application could be replicated upon double stimulation to persistently improve systemic glucose tolerance and stress axes activity in humans. In a single-blinded cross-over study, we examined 15 healthy male volunteers. Anodal tDCS vs sham was applied twice in series. Systemic glucose tolerance was investigated by the standard hyperinsulinaemic-euglycaemic glucose clamp procedure, and parameters of neurohormonal stress axes activity were measured. Because tDCS-induced brain energy consumption has been shown to be part of the mechanism underlying the assumed effects, we monitored the cerebral high-energy phosphates ATP and phosphocreatine by
Substances chimiques
Blood Glucose
0
Phosphocreatine
020IUV4N33
Adenosine Triphosphate
8L70Q75FXE
Glucose
IY9XDZ35W2
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12688Informations de copyright
© 2019 British Society for Neuroendocrinology.